Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines

Chest

Volumn 143, Issue 5 SUPPL, 2013, Pages

  Brunelli, Alessandro ^a   Kim, Anthony W ^b   Berger, Kenneth I ^c   Addrizzo Harris, Doreen J ^d  

^a Division of Thoracic Surgery   (Italy)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Medicine ^*  (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBON MONOXIDE;

ANATOMIC LANDMARK; ARTICLE; BRADYCARDIA; CANCER ADJUVANT THERAPY; CANCER REHABILITATION; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLIMBING; DISABILITY; EXERCISE TEST; FORCED EXPIRATORY VOLUME; HEART INFARCTION; HUMAN; HUMAN TISSUE; HYPOTENSION; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; LUNG CANCER; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG RESECTION; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MORBIDITY; NONHUMAN; ONSET AGE; OXYGEN CONSUMPTION; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; PULMONARY REHABILITATION; RISK ASSESSMENT; SCORING SYSTEM; SHUTTLE WALK TEST; SMOKING CESSATION; SPIROMETRY; STAIR CLIMBING TEST; SURGICAL ANATOMY; SURGICAL MORTALITY; SURVIVAL TIME; TASK PERFORMANCE; WALKING;

EID: 84877653031     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2395     Document Type: Article

References (245)

1. Lewis SZ, Diekemper R, Addrizzo-Harris DJ. Methodology for development of guidelines for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143 (5)(suppl):41S-50S.
2. Beckles MA, Spiro SG, Colice GL, Rudd RM; American College of Chest Physicians. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest. 2003; 123 (suppl 1): 105S-114S.
3. Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT; American College of Chest Physicians. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007; 132(suppl 3): 161S-177S.
4. Burke JR, Duarte IG, Thourani VH, Miller JI Jr. Preoperative risk assessment for marginal patients requiring pulmonary resection. Ann Thorac Surg. 2003; 76 (5): 1767-1773.
5. Ferguson MK. Preoperative assessment of pulmonary risk. Chest. 1999; 115 (suppl 5): 58S-63S.
6. Reilly JJ Jr. Evidence-based preoperative evaluation of candidates for thoracotomy. Chest. 1999; 116(suppl 6): 474S-476S.
7. Bolliger CT, Perruchoud AP. Functional evaluation of the lung resection candidate. Eur Respir J. 1998; 11(1):198-212.
8. Bolliger CT, Koegelenberg CF, Kendal R. Preoperative assessment for lung cancer surgery. Curr Opin Pulm Med. 2005; 11 (4): 301-306.
9. Datta D, Lahiri B. Preoperative evaluation of patients undergoing lung resection surgery. Chest. 2003; 123 (6): 2096-2103.
10. Felip E, Stahel RA, Pavlidis N. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC). Ann Oncol. 2005; 16(suppl 1):i28-29.
11. Depierre A, Lagrange JL, Theobald S, et al; FNCLCC. Summary report of the Standards, Options and Recommendations for the management of patients with non-smallcell lung carcinoma (2000). Br J Cancer. 2003; 89(suppl 1): S35-S49.
12. Lowe G, Twaddle S. The Scottish Intercollegiate Guidelines Network (SIGN): an update. Scott Med J. 2005; 50 (2): 51-52.
13. Wood E. The National Comprehensive Cancer Netowrk (NCCN). J Med Libr Assoc. 2004; 92 (3): 382-383.
14. National Cancer Institute. Non-small cell lung cancer (PDQ): Treatment. National Cancer Institute website. http://www.cancer.gov. Accessed May 2005.
15. Central European Cooperative Oncology Group (CECOG); Advisory Committee on Collaboration with Industry in Medical Education of the European School of Oncolofy (ESO); Vienna Medical Association. Consensus on medical treatment of non-small cell lung cancer. Lung Cancer. 2002; 38 (suppl 3): S3-S7.
16. Baldwin DR, White B, Schmidt-Hansen M, Champion AR, Melder AM. Guideline Development Group. Diagnosis and treatment of lung cancer: summary of updated NICE guidance. BMJ. 2011; 342:d2110.
17. Lim E, Baldwin D, Beckles M, et al. Guidelines on the radical management of patients with lung cancer. Thorax. 2010; 65 (suppl 3): iii1-27.
18. Brunelli A, Charloux A, Bolliger CT, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J. 2009; 34(1):17-41.
19. Muers MF, Haward RA. Management of lung cancer. Thorax. 1996; 51 (6): 557-560.
20. Brown JS, Eraut D, Trask C, Davison AG. Age and the treatment of lung cancer. Thorax. 1996; 51 (6): 564-568.
21. Coory M, Gkolia P, Yang IA, Bowman RV, Fong KM. Systematic review of multidisciplinary teams in the management of lung cancer. Lung Cancer. 2008; 60 (1): 14-21.
22. Price A KG, Gregor A, Ironside J, Little F. The impact of multidisciplinary teams and site specialisation on the use of radiotherapy in elderly people with non-small cell lung cancer (NSCLC). Radiotherapy and Oncology. 2002; 64(suppl 1): S80
23. Forrest LM, McMillan DC, McArdle CS, Dunlop DJ. An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2005; 93 (9): 977-978.
24. Bowen EF, Anderson JR, Roddie ME. Improving surgical resection rates in lung cancer without a two stop service. Thorax. 2003; 58 (4): 368.
25. Davison AG, Eraut CD, Haque AS, et al. Telemedicine for multidisciplinary lung cancer meetings. J Telemed Telecare. 2004; 10 (3): 140-143.
26. Boxer MM, Vinod SK, Shafiq J, Duggan KJ. Do multidisciplinary team meetings make a difference in the management of lung cancer? Cancer. 2011; 117 (22): 5112-5120.
27. Freeman RK, Van Woerkom JM, Vyverberg A, Ascioti AJ. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer. Eur J Cardiothorac Surg. 2010; 38(1):1-5.
28. Dowie J, Wildman M. Choosing the surgical mortality threshold for high risk patients with stage Ia non-small cell lung cancer: insights from decision analysis. Thorax. 2002; 57 (1): 7-10.
29. Pallis AG, Gridelli C, van Meerbeeck JP, et al. EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population. Ann Oncol. 2010; 21(4):692-706.
30. Brock MV, Kim MP, Hooker CM, et al. Pulmonary resection in octogenarians with stage I nonsmall cell lung cancer: a 22-year experience. Ann Thorac Surg. 2004; 77 (1): 271-277.
31. Port JL, Kent M, Korst RJ, et al. Surgical resection for lung cancer in the octogenarian. Chest. 2004; 126 (3): 733-738.
32. Allen MS, Darling GE, Pechet TT, et al; ACOSOG Z0030 Study Group. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006; 81 (3): 1013-1019.
33. Berry MF, Onaitis MW, Tong BC, Harpole DH, D'Amico TA. A model for morbidity after lung resection in octogenarians. Eur J Cardiothorac Surg. 2011; 39(6):989-994.
34. Cerfolio RJ, Bryant AS. Survival and outcomes of pulmonary resection for non-small cell lung cancer in the elderly: a nested case-control study. Ann Thorac Surg. 2006; 82 (2): 424-429., discussion 429-430.
35. Fanucchi O, Ambrogi MC, Dini P, et al. Surgical treatment of non-small cell lung cancer in octogenarians. Interact Cardiovasc Thorac Surg. 2011; 12 (5): 749-753.
36. Igai H, Takahashi M, Ohata K, et al. Surgical treatment for non-small cell lung cancer in octogenarians-the usefulness of video-assisted thoracic surgery. Interact Cardiovasc Thorac Surg. 2009; 9 (2): 274-277.
37. Matsuoka H, Okada M, Sakamoto T, Tsubota N. Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age. Eur J Cardiothorac Surg. 2005; 28(3):380-383.
38. Mun M, Kohno T. Video-assisted thoracic surgery for clinical stage I lung cancer in octogenarians. Ann Thorac Surg. 2008; 85 (2): 406-411.
39. Rivera C, Dahan M, Bernard A, Falcoz PE, Thomas P. Surgical treatment of lung cancer in the octogenarians: results of a nationwide audit. Eur J Cardiothorac Surg. 2011; 39(6):981-986.
40. Sawada S, Komori E, Nogami N, et al. Advanced age is not correlated with either short-term or long-term postoperative results in lung cancer patients in good clinical condition. Chest. 2005; 128 (3): 1557-1563.
41. Brokx HA, Visser O, Postmus PE, Paul MA. Surgical treatment for octogenarians with lung cancer: results from a population-based series of 124 patients. J Thorac Oncol. 2007; 2(11):1013-1017.
42. Dillman RO, Zusman DR, McClure SE. Surgical resection and long-term survival for octogenarians who undergo surgery for non-small-cell lung cancer. Clin Lung Cancer. 2009; 10 (2): 130-134.
43. Finlayson E, Fan Z, Birkmeyer JD. Outcomes in octogenarians undergoing high-risk cancer operation: a national study. J Am Coll Surg. 2007; 205 (6): 729-734.
44. Owonikoko TK, Ragin CC, Belani CP, et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol. 2007; 25(35): 5570-5577.
45. Dhand R. Aerosol therapy during mechanical ventilation: getting ready for prime time. Am J Respir Crit Care Med. 2003; 168 (10): 1148-1149.
46. Voltolini L, Rapicetta C, Ligabue T, Luzzi L, Scala V, Gotti G. Short-and long-term results of lung resection for cancer in octogenarians. Asian Cardiovasc Thorac Ann. 2009; 17 (2): 147-152.
47. Dominguez-Ventura A, Allen MS, Cassivi SD, Nichols FC III, Deschamps C, Pairolero PC. Lung cancer in octogenarians: factors affecting morbidity and mortality after pulmonary resection. Ann Thorac Surg. 2006; 82 (4): 1175-1179.
48. Brunelli A, Varela G, Salati M, et al. Recalibration of the revised cardiac risk index in lung resection candidates. Ann Thorac Surg. 2010; 90 (1): 199-203.
49. Brunelli A, Cassivi SD, Fibla J, et al. External validation of the recalibrated thoracic revised cardiac risk index for predicting the risk of major cardiac complications after lung resection. Ann Thorac Surg. 2011; 92 (2): 445-448.
50. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999; 100 (10): 1043-1049.
51. Fleisher LA, Beckman JA, Brown KA, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery); American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society for Vascular Surgery. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007; 116 (17): e418-e499.
52. Poldermans D, Bax JJ, Boersma E, et al; Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery; European Society of Cardiology (ESC). Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J. 2009; 30 (22): 2769-2812.
53. Ferguson MK, Celauro AD, Vigneswaran WT. Validation of a modified scoring system for cardiovascular risk associated with major lung resection. Eur J Cardiothorac Surg. 2012; 41(3):598-602.
54. Eagle KA, Berger PB, Calkins H, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Non cardiac Surgery). ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guide lines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2002; 105 (10): 1257-1267.
55. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004; 351 (27): 2795-2804.
56. Poldermans D, Schouten O, Vidakovic R, et al; DECREASE Study Group. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol. 2007; 49 (17): 1763-1769.
57. Douketis JD, Berger PB, Dunn AS, et al; American College of Chest Physicians. The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008; 133 (suppl 6): 299S-339S.
58. Cerfolio RJ, Minnich DJ, Bryant AS. General thoracic surgery is safe in patients taking clopidogrel (Plavix). J Thorac Cardiovasc Surg. 2010; 140 (5): 970-976.
59. Brady AR, Gibbs JS, Greenhalgh RM, Powell JT, Sydes MR; POBBLE trial investigators. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg. 2005; 41 (4): 602-609.
60. Yang H, Raymer K, Butler R, Parlow J, Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J. 2006; 152 (5): 983-990.
61. Devereaux PJ, Yang H, Yusuf S, et al; POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008; 371 (9627): 1839-1847.
62. Poldermans D, Boersma E, Bax JJ, et al; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. The effect of bisoprolol on perioperative mortality and myocardial infarction in highrisk patients undergoing vascular surgery. N Engl J Med. 1999; 341 (24): 1789-1794.
63. Pinkstaff S, Peberdy MA, Kontos MC, Fabiato A, Finucane S, Arena R. Usefulness of decrease in oxygen uptake effi-ciency slope to identify myocardial perfusion defects in men undergoing myocardial ischemic evaluation. Am J Cardiol. 2010; 106 (11): 1534-1539.
64. Chaudhry S, Arena R, Wasserman K, et al. Exercise-induced myocardial ischemia detected by cardiopulmonary exercise testing. Am J Cardiol. 2009; 103 (5): 615-619.
65. Chaudhry S, Arena RA, Hansen JE, et al. The utility of car diopulmonary exercise testing to detect and track earlystage ischemic heart disease. Mayo Clin Proc. 2010; 85 (10): 928-932.
66. Belardinelli R, Lacalaprice F, Carle F, et al. Exerciseinduced myocardial ischaemia detected by cardiopulmonary exercise testing. Eur Heart J. 2003; 24 (14): 1304-1313.
67. Martin-Ucar AE, Waller DA, Atkins JL, Swinson D, O'Byrne KJ, Peake MD. The beneficial effects of specialist thoracic surgery on the resection rate for non-small-cell lung cancer. Lung Cancer. 2004; 46 (2): 227-232.
68. Silvestri GA, Handy J, Lackland D, Corley E, Reed CE. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest. 1998; 114 (3): 675-680.
69. Schipper PH, Diggs BS, Ungerleider RM, Welke KF. The influence of surgeon specialty on outcomes in general thoracic surgery: a national sample 1996 to 2005. Ann Thorac Surg. 2009; 88(5):1566-1572.
70. Goodney PP, Lucas FL, Stukel TA, Birkmeyer JD. Surgeon specialty and operative mortality with lung resection. Ann Surg. 2005; 241 (1): 179-184.
71. Farjah F, Flum DR, Varghese TK Jr, Symons RG, Wood DE. Surgeon specialty and long-term survival after pulmonary resection for lung cancer. Ann Thorac Surg. 2009; 87 (4): 995-1004.
72. Romano PS, Mark DH. Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest. 1992; 101 (5): 1332-1337.
73. Finlayson EV, Goodney PP, Birkmeyer JD. Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg. 2003; 138 (7): 721-725.
74. Bach PB, Cramer LD, Schrag D, Downey RJ, Gelfand SE, Begg CB. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med. 2001; 345(3): 181-188.
75. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002; 346 (15): 1128-1137.
76. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003; 349 (22): 2117-2127.
77. Hannan EL, Radzyner M, Rubin D, Dougherty J, Brennan MF. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery. 2002; 131 (1): 6-15.
78. Cheung MC, Hamilton K, Sherman R, et al. Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients. Ann Surg Oncol. 2009; 16 (1): 3-13.
79. Little AG, Rusch VW, Bonner JA, et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg. 2005; 80 (6): 2051-2056.
80. Bilimoria KY, Bentrem DJ, Feinglass JM, et al. Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol. 2008; 26(28):4626-4633.
81. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998; 280 (20): 1747-1751.
82. Urbach DR, Bell CM, Austin PC. Differences in operative mortality between high-and low-volume hospitals in Ontario for 5 major surgical procedures: estimating the number of lives potentially saved through regionalization. CMAJ. 2003; 168(11):1409-1414.
83. Freixinet JL, Julia-Serda G, Rodriguez PM, et al. Hospital volume: operative morbidity, mortality and survival in thoracotomy for lung cancer. A Spanish multicenter study of 2994 cases. Eur J Cardiothorac Surg. 2006; 29(1):20-25.
84. Wouters MW, Siesling S, Jansen-Landheer ML, et al. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol. 2010;36(suppl 1):S83-92.
85. Treasure T, Utley M, Bailey A. Assessment of whether in-hospital mortality for lobectomy is a useful standard for the quality of lung cancer surgery: retrospective study. BMJ. 2003; 327 (7406): 73-75.
86. Simunovic M, Rempel E, Theriault ME, et al. Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario. Can J Surg. 2006; 49(4):251-258.
87. Finlayson EV, Birkmeyer JD. Effects of hospital volume on life expectancy after selected cancer operations in older adults: a decision analysis. J Am Coll Surg. 2003; 196(3): 410-417.
88. Birkmeyer JD, Sun Y, Wong SL, Stukel TA. Hospital volume and late survival after cancer surgery. Ann Surg. 2007; 245 (5): 777-783.
89. Lien YC, Huang MT, Lin HC. Association between surgeon and hospital volume and in-hospital fatalities after lung cancer resections: the experience of an Asian country. Ann Thorac Surg. 2007; 83 (5): 1837-1843.
90. Damhuis RAM, Schütte PR. Resection rates and postoperative mortality in 7,899 patients with lung cancer. Eur Respir J. 1996; 9 (1): 7-10.
91. Cerfolio RJ, Bryant AS, Patel B, Bartolucci AA. Intercostal muscle flap reduces the pain of thoracotomy: a prospective randomized trial. J Thorac Cardiovasc Surg. 2005; 130 (4): 987-993.
92. Paul S, Altorki NK, Sheng S, et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg. 2010; 139 (2): 366-378.
93. Swanson SJ, Herndon JE II, D'Amico TA, et al. Videoassisted thoracic surgery lobectomy: report of CALGB 39802-a prospective, multi-institution feasibility study. J Clin Oncol. 2007; 25 (31): 4993-4997.
94. MelfiFM, Mussi A. Robotically assisted lobectomy: learning curve and complications. Thorac Surg Clin. 2008; 18 (3): 289-295, vi-vii.
95. Berry MF, Villamizar-Ortiz NR, Tong BC, et al. Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy. Ann Thorac Surg. 2010; 89 (4): 1044-1051.
96. Iwasaki A, Shirakusa T, Enatsu S, Maekawa S, Yoshida Y, Yoshinaga Y. Surgical treatment for lung cancer with COPD based on the global initiative for chronic obstructive lung disease (GOLD). Thorac Cardiovasc Surg. 2005; 53 (3): 162-167.
97. Ferguson MK, Siddique J, Karrison T. Modeling major lung resection outcomes using classification trees and multiple imputation techniques. Eur J Cardiothorac Surg. 2008; 34 (5): 1085-1089.
98. Koizumi KHS, Haraguchi S, Hirata T, et al. Surgical treatment for lung cancer patients with poor pulmonary function. Ann Thorac Cardiovasc Surg. 2005; 11 (2): 87-92.
99. Licker MJ, Widikker I, Robert J, et al. Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann Thorac Surg. 2006; 81 (5): 1830-1837.
100. Magdeleinat P, Seguin A, Alifano M, Boubia S, Regnard JF. Early and long-term results of lung resection for non-small-cell lung cancer in patients with severe ventilatory impairment. Eur J Cardiothorac Surg. 2005; 27 (6): 1099-1105.
101. Garzon JC, Ng CSH, Sihoe ADL, et al. Video-assisted thoracic surgery pulmonary resection for lung cancer in patients with poor lung function. Ann Thorac Surg. 2006; 81 (6): 1996-2003.
102. Brunelli A, Al Refai M, Monteverde M, Sabbatini A, Xiumé F, Fianchini A. Predictors of early morbidity after major lung resection in patients with and without airflow limitation. Ann Thorac Surg. 2002; 74 (4): 999-1003.
103. Linden PA, Bueno R, Colson YL, et al. Lung resection in patients with preoperative FEV1, 35% predicted. Chest. 2005; 127 (6): 1984-1990.
104. Sekine Y, Iwata T, Chiyo M, et al. Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease. Ann Thorac Surg. 2003; 76 (2): 356-361.
105. Brunelli A, Xiumé F, Refai M, et al. Evaluation of expiratory volume, diffusion capacity, and exercise tolerance following major lung resection: a prospective follow-up analysis. Chest. 2007; 131 (1): 141-147.
106. Edwards JG, Duthie DJR, Waller DA. Lobar volume reduction surgery: a method of increasing the lung cancer resection rate in patients with emphysema. Thorax. 2001; 56(10): 791-795.
107. Carretta A, Zannini P, Puglisi A, et al. Improvement of pulmonary function after lobectomy for non-small cell lung cancer in emphysematous patients. Eur J Cardiothorac Surg. 1999; 15 (5): 602-607.
108. Korst RJ, Ginsberg RJ, Ailawadi M, et al. Lobectomy improves ventilatory function in selected patients with severe COPD. Ann Thorac Surg. 1998; 66 (3): 898-902.
109. Santambrogio L, Nosotti M, Baisi A, Ronzoni G, Bellaviti N, Rosso L. Pulmonary lobectomy for lung cancer: a prospective study to compare patients with forced expiratory volume in 1 s more or less than 80% of predicted. Eur J Cardiothorac Surg. 2001; 20 (4): 684-687.
110. Baldi S, Ruffini E, Harari S, et al. Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study. J Thorac Cardiovasc Surg. 2005; 130 (6): 1616-1622.
111. Brunelli A, Refai M, Salati M, Xiumé F, Sabbatini A. Predicted versus observed FEV1 and DLCO after major lung resection: a prospective evaluation at different postoperative periods. Ann Thorac Surg. 2007; 83 (3): 1134-1139.
112. Brunelli A, Sabbatini A, Xiumé F, et al. A model to predict the decline of the forced expiratory volume in one second and the carbon monoxide lung diffusion capacity early after major lung resection. Interact Cardiovasc Thorac Surg. 2005; 4(1):61-65.
113. Ferguson MK, Little L, Rizzo L, et al. Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg. 1988; 96 (6): 894-900.
114. Markos J, Mullan BP, Hillman DR, et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis. 1989; 139 (4): 902-910.
115. Cerfolio RJ, Bryant AS. Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity. Ann Thorac Surg. 2009; 88 (2): 405-410.
116. Pierce RJ, Copland JM, Sharpe K, Barter CE. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality. Am J Respir Crit Care Med. 1994; 150 (4): 947-955.
117. Ferguson MK, Reeder LB, Mick R. Optimizing selection of patients for major lung resection. J Thorac Cardiovasc Surg. 1995; 109 (2): 275-281.
118. Santini M, Fiorello A, Vicidomini G, Di Crescenzo VG, Laperuta P. Role of diffusing capacity in predicting complications after lung resection for cancer. Thorac Cardiovasc Surg. 2007; 55 (6): 391-394.
119. Brunelli A, Refai MA, Salati M, Sabbatini A, Morgan-Hughes NJ, Rocco G. Carbon monoxide lung diffusion capacity improves risk stratification in patients without airflow limitation: evidence for systematic measurement before lung resection. Eur J Cardiothorac Surg. 2006; 29 (4): 567-570.
120. Ferguson MK, Vigneswaran WT. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ann Thorac Surg. 2008; 85 (4): 1158-1164.
121. Liptay MJ, Basu S, Hoaglin MC, et al. Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer. J Surg Oncol. 2009; 100 (8): 703-707.
122. Ferguson M, Dignam JJ, Siddique J, Vidneswaran WT, Celauro AD. Diffusing capacity predicts long-term survival after lung resection for cancer. Eur J Cardiothorac Surg. 2012; 41 (5): e81-e86.
123. Handy JR Jr, Asaph JW, Skokan L, et al. What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest. 2002; 122 (1): 21-30.
124. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005; 26(4):720-735.
125. Miller MR, Hankinson J, Brusasco V, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005; 26 (2): 319-338.
126. Bolliger CT, Gückel C, Engel H, et al. Prediction of functional reserves after lung resection: comparison between quantitative computed tomography, scintigraphy, and anatomy. Respiration. 2002; 69 (6): 482-489.
127. Alam N, Park BJ, Wilton A, et al. Incidence and risk factors for lung injury after lung cancer resection. Ann Thorac Surg. 2007; 84 (4): 1085-1091.
128. Martin-Ucar AE, Fareed KR, Nakas A, Vaughan P, Edwards JG, Waller DA. Is the initial feasibility of lobectomy for stage I non-small cell lung cancer in severe heterogeneous emphysema justified by long-term survival? Thorax. 2007; 62 (7): 577-580.
129. Lau KKW, Martin-Ucar AE, Nakas A, Waller DA. Lung cancer surgery in the breathless patient-the benefits of avoiding the gold standard. Eur J Cardiothorac Surg. 2010; 38 (1): 6-13.
130. Endoh H, Tanaka S, Yajima T, et al. Pulmonary function after pulmonary resection by posterior thoracotomy, anterior thoracotomy or video-assisted surgery. Eur J Cardiothorac Surg. 2010; 37 (5): 1209-1214.
131. Bobbio A, Chetta A, Carbognani P, et al. Changes in pulmonary function test and cardio-pulmonary exercise capacity in COPD patients after lobar pulmonary resection. Eur J Cardiothorac Surg. 2005; 28 (5): 754-758.
132. Kushibe K, Takahama M, Tojo T, Kawaguchi T, Kimura M, Taniguchi S. Assessment of pulmonary function after lobectomy for lung cancer-upper lobectomy might have the same effect as lung volume reduction surgery. Eur J Cardiothorac Surg. 2006; 29 (6): 886-890.
133. Varela G, Brunelli A, Rocco G, Jiménez MF, Salati M, Gatani T. Evidence of lower alteration of expiratory volume in patients with airflow limitation in the immediate period after lobectomy. Ann Thorac Surg. 2007; 84 (2): 417-422.
134. Luzzi L, Tenconi S, Voltolini L, et al. Long-term respiratory functional results after pneumonectomy. Eur J Cardiothorac Surg. 2008; 34 (1): 164-168.
135. Varela G, Brunelli A, Rocco G, et al. Predicted versus observed FEV1 in the immediate postoperative period after pulmonary lobectomy. Eur J Cardiothorac Surg. 2006; 30 (4): 644-648.
136. Varela G, Brunelli A, Rocco G, et al. Measured FEV1 in the first postoperative day, and not ppoFEV1, is the best predictor of cardio-respiratory morbidity after lung resection. Eur J Cardiothorac Surg. 2007; 31 (3): 518-521.
137. Brunelli A, Varela G, Rocco G, et al. A model to predict the immediate postoperative FEV1 following major lung resections. Eur J Cardiothorac Surg. 2007; 32(5):783-786.
138. 1 and diffusing capacity of the lung for carbon monoxide, 40%. Chest. 2011; 139 (6): 1430-1438.
139. Brunelli A, Refai M, Xiumé F, et al. Performance at symptomlimited stair-climbing test is associated with increased cardiopulmonary complications, mortality, and costs after major lung resection. Ann Thorac Surg. 2008; 86 (1): 240-247.
140. Holden DA, Rice TW, Stelmach K, Meeker DP. Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection. Chest. 1992; 102 (6): 1774-1779.
141. Bechard D, Wetstein L. Assessment of exercise oxygen consumption as preoperative criterion for lung resection. Ann Thorac Surg. 1987; 44 (4): 344-349.
142. Olsen GN, Weiman DS, Bolton JWR, et al. Submaximal invasive exercise testing and quantitative lung scanning in the evaluation for tolerance of lung resection. Chest. 1989; 95 (2): 267-273.
143. Benzo R, Kelley GA, Recchi L, Hofman A, Sciurba F. Complications of lung resection and exercise capacity: a meta-analysis. Respir Med. 2007; 101 (8): 1790-1797.
144. Loewen GM, Watson D, Kohman L, et al; Cancer and Leukemia Group B. Preoperative exercise Vo2 measurement for lung resection candidates: results of Cancer and Leukemia Group B Protocol 9238. J Thorac Oncol. 2007; 2(7): 619-625.
145. Bayram AS, Candan T, Gebitekin C. Preoperative maximal exercise oxygen consumption test predicts postoperative pulmonary morbidity following major lung resection. Respirology. 2007; 12 (4): 505-510.
146. Torchio R, Guglielmo M, Giardino R, et al. Exercise ventilatory inefficiency and mortality in patients with chronic obstructive pulmonary disease undergoing surgery for nonsmall-cell lung cancer. Eur J Cardiothorac Surg. 2010; 38 (1): 14-19.
147. Bobbio A, Chetta A, Internullo E, et al. Exercise capacity assessment in patients undergoing lung resection. Eur J Cardiothorac Surg. 2009; 35 (3): 419-422.
148. Brunelli A, Belardinelli R, Refai M, et al. Peak oxygen consumption during cardiopulmonary exercise test improves risk stratification in candidates to major lung resection. Chest. 2009; 135 (5): 1260-1267.
149. Walsh GL, Morice RC, Putnam JB Jr, et al. Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption. Ann Thorac Surg. 1994; 58(3): 704-710.
150. Wang J, Olak J, Ultmann RE, Ferguson MK. Assessment of pulmonary complications after lung resection. Ann Thorac Surg. 1999; 67 (5): 1444-1447.
151. Bolliger CT, Jordan P, Solèr M, et al. Exercise capacity as a predictor of postoperative complications in lung resection candidates. Am J Respir Crit Care Med. 1995; 151 (5): 1472-1480.
152. Win T, Jackson A, Sharples L, et al. Cardiopulmonary exercise tests and lung cancer surgical outcome. Chest. 2005; 127 (4): 1159-1165.
153. Smith TP, Kinasewitz GT, Tucker WY, Spillers WP, George RB. Exercise capacity as a predictor of post-thoracotomy morbidity. Am Rev Respir Dis. 1984; 129 (5): 730-734.
154. Birim O, Kappetein AP, Goorden T, van Klaveren RJ, Bogers AJJC. Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer. Ann Thorac Surg. 2005; 80 (3): 1021-1026.
155. Brutsche MH, Spiliopoulos A, Bolliger CT, Licker M, Frey JG, Tschopp JM. Exercise capacity and extent of resection as predictors of surgical risk in lung
156. Kozower BD, Sheng SB, O'Brien SM, et al. STS database risk models: predictors of mortality and major morbidity for lung cancer resection. Ann Thorac Surg. 2010; 90(3): 875-881.
157. Win T, Jackson A, Groves AM, Sharples LD, Charman SC, Laroche CM. Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer. Thorax. 2006; 61 (1): 57-60.
158. Epstein SK, Faling LJ, Daly BDT, Celli BR. Predicting complications after pulmonary resection. Preoperative exercise testing vs a multifactorial cardiopulmonary risk index. Chest. 1993; 104 (3): 694-700.
159. Richter Larsen K, Svendsen UG, Milman N, Brenøe J, Petersen BN. Exercise testing in the preoperative evaluation of patients with bronchogenic carcinoma. Eur Respir J. 1997; 10 (7): 1559-1565.
160. Morice RC, Peters EJ, Ryan MB, Putnam JB, Ali MK, Roth JA. Exercise testing in the evaluation of patients at high risk for complications from lung resection. Chest. 1992; 101 (2): 356-361.
161. Bolliger CT, Wyser C, Roser H, Solèr M, Perruchoud AP. Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications. Chest. 1995; 108 (2): 341-348.
162. Kasikcioglu E, Toker A, Tanju S, et al. Oxygen uptake kinetics during cardiopulmonary exercise testing and postoperative complications in patients with lung cancer. Lung Cancer. 2009; 66 (1): 85-88.
163. Saumon G. Pump and circumstances. A m J Respir Crit Care Med. 2003; 168 (12): 1408-1409.
164. Brunelli A, Belardinelli R, Pompili C, et al. Minute ventilationto-carbon dioxide output (VE/VCO2) slope is the strongest predictor of respiratory complications and death after pulmonary resection. Ann Thorac Surg. 2012; 93 (6): 1802-1806.
165. Ribas J, Díaz O, Barberà JA, et al. Invasive exercise testing in the evaluation of patients at high-risk for lung resection. Eur Respir J. 1998; 12 (6): 1429-1435.
166. Bolliger CT, Solèr M, Stulz P, et al. Evaluation of high-risk lung resection candidates: pulmonary haemodynamics versus exercise testing. A series of five patients. Respiration. 1994; 61 (4): 181-186.
167. Wang JS, Abboud RT, Evans KG, Finley RJ, Graham BL. Role of CO diffusing capacity during exercise in the preoperative evaluation for lung resection. Am J Respir Crit Care Med. 2000; 162 (4 Pt 1): 1435-1444.
168. Vidal Melo MF, Barazanji K, Winga E, Johnson RL. Estimate of pulmonary diffusing capacity for oxygen during exercise in humans from routine O(2) and CO(2) measurements. Clin Physiol Funct Imaging. 2004; 24 (1): 46-57.
169. Swinburn CR, Wakefield JM, Jones PW. Performance, ventilation, and oxygen consumption in three different types of exercise test in patients with chronic obstructive lung disease. Thorax. 1985; 40 (8): 581-586.
170. Pollock M, Roa J, Benditt J, Celli B. Estimation of ventilatory reserve by stair climbing. A study in patients with chronic airflow obstruction. Chest. 1993; 104 (5): 1378-1383.
171. Bolton JWR, Weiman DS, Haynes JL, Hornung CA, Olsen GN, Almond CH. Stair climbing as an indicator of pulmonary function. Chest. 1987; 92 (5): 783-788.
172. Brunelli A, Al Refai M, Monteverde M, Borri A, Salati M, Fianchini A. Stair climbing test predicts cardiopulmonary complications after lung resection. Chest. 2002; 121 (4): 1106-1110.
173. Olsen GN, Bolton JWR, Weiman DS, Hornung CA. Stair climbing as an exercise test to predict the postoperative complications of lung resection. Two years' experience. Chest. 1991; 99 (3): 587-590.
174. Brunelli A, Xiumé F, Refai M, et al. Peak oxygen consumption measured during the stair-climbing test in lung resection candidates. Respiration. 2010; 80 (3): 207-211.
175. Koegelenberg CFN, Diacon AH, Irani S, Bolliger CT. Stair climbing in the functional assessment of lung resection candidates. Respiration. 2008; 75 (4): 374-379.
176. Toker A, Ziyade S, Bayrak Y, et al. Prediction of cardiopulmonary morbidity after resection for lung cancer: stair climbing test complications after lung cancer surgery. Thorac Cardiovasc Surg. 2007; 55 (4): 253-256.
177. Brunelli A, Sabbatini A, Xiume' F, et al. Inability to perform maximal stair climbing test before lung resection: a propensity score analysis on early outcome. Eur J Cardiothorac Surg. 2005; 27 (3): 367-372.
178. Brunelli A, Monteverde M, Al Refai M, Fianchini A. Stair climbing test as a predictor of cardiopulmonary complications after pulmonary lobectomy in the elderly. Ann Thorac Surg. 2004; 77 (1): 266-270.
179. Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest. 2001; 119 (1): 256-270.
180. Singh SJ, Morgan MDL, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992; 47 (12): 1019-1024.
181. Win T, Jackson A, Groves AM, et al. Relationship of shuttle walk test and lung cancer surgical outcome. Eur J Cardiothorac Surg. 2004; 26 (6): 1216-1219.
182. Benzo RP, Sciurba FC. Oxygen consumption, shuttle walking test and the evaluation of lung resection. Respiration. 2010; 80 (1): 19-23.
183. Crapo RO, Casaburi R, Coates AL, et al; ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1): 111-117.
184. Brunelli APC, Pompili C, Salati M. Low-technology exercise test in the preoperative evaluation of lung resection candidates. Monaldi Arch Chest Dis. 2010; 73 (2): 72-78.
185. Turner SE, Eastwood PR, Cecins NM, Hillman DR, Jenkins SC. Physiologic responses to incremental and self-paced exercise in COPD: a comparison of three tests. Chest. 2004; 126 (3): 766-773.
186. Ninan M, Sommers KE, Landreneau RJ, et al. Standardized exercise oximetry predicts postpneumonectomy outcome. Ann Thorac Surg. 1997; 64 (2): 328-332.
187. Rao V, Todd TRJ, Kuus A, Buth KJ, Pearson FG. Exercise oximetry versus spirometry in the assessment of risk prior to lung resection. Ann Thorac Surg. 1995; 60 (3): 603-608.
188. Brunelli A, Refai M, Xiumé F, et al. Oxygen desaturation during maximal stair-climbing test and postoperative complications after major lung resections. Eur J Cardiothorac Surg. 2008; 31 (1): 77-82.
189. Varela G, Cordovilla R, Jiménez MF, Novoa N. Utility of standardized exercise oximetry to predict cardiopulmonary morbidity after lung resection. Eur J Cardiothorac Surg. 2001; 19 (3): 351-354.
190. Melendez JA, Barrera R. Predictive respiratory complication quotient predicts pulmonary complications in thoracic surgical patients. Ann Thorac Surg. 1998; 66 (1): 224-240.
191. published correction appears in Ann Thorac Surg. 1998;6(6):2164
192. Brunelli A, Fianchini A, Gesuita R, Carle F. POSSUM scoring system as an instrument of audit in lung resection surgery. Physiological and operative severity score for the enumeration of mortality and morbidity. Ann Thorac Surg. 1999; 67 (2): 329-331.
193. Ferguson MK, Durkin AE. A comparison of three scoring systems for predicting complications after major lung resection. Eur J Cardiothorac Surg. 2003; 23 (1): 35-42.
194. Berrisford R, Brunelli A, Rocco G, Treasure T, Utley M; Audit and guidelines committee of the European Society of Thoracic Surgeons; European Association of Cardiothoracic Surgeons. The European Thoracic Surgery Data base project: modelling the risk of in-hospital death following lung resection. Eur J Cardiothorac Surg. 2005; 28 (2): 306-311.
195. Falcoz PE, Conti M, Brouchet L, et al. The Thoracic Surgery Scoring System (Thoracoscore): risk model for in-hospital death in 15,183 patients requiring thoracic surgery. J Thorac Cardiovasc Surg. 2007; 133 (2): 325-332.
196. Celli BR. What is the value of preoperative pulmonary function testing? Med Clin North Am. 1993; 77 (2): 309-325.
197. Zibrak JD, O'Donnell CR, Marton K. Indications for pulmonary function testing. Ann Intern Med. 1990; 112 (10): 763-771.
198. Tisi GM. Preoperative evaluation of pulmonary function. Validity, indications, and benefits. Am Rev Respir Dis. 1979; 119 (2): 293-310.
199. Stein M, Koota GM, Simon M, Frank HA. Pulmonary evaluation of surgical patients. JAMA. 1962; 181 (9): 765-770.
200. Kearney DJ, Lee TH, Reilly JJ, DeCamp MM, Sugarbaker DJ. Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. Chest. 1994; 105 (3): 753-759.
201. Harpole DH, Liptay MJ, DeCamp MM Jr, Mentzer SJ, Swanson SJ, Sugarbaker DJ. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg. 1996; 61 (3): 977-982.
202. Brooks D, Solway S, Gibbons WJ. ATS statement on six-minute walk test. Am J Respir Crit Care Med. 2003; 167 (9): 1287.
203. Olsen GN, Block AJ, Tobias JA. Prediction of postpneumonectomy pulmonary function using quantitative macroaggregate lung scanning. Chest. 1974; 66 (1): 13-16.
204. Nezu K, Kushibe K, Tojo T, Takahama M, Kitamura S. Recovery and limitation of exercise capacity after lung resection for lung cancer. Chest. 1998; 113 (6): 1511-1516.
205. Bolliger CT, Jordan P, Solèr M, et al. Pulmonary function and exercise capacity after lung resection. Eur Respir J. 1996; 9 (3): 415-421.
206. Pelletier C, Lapointe L, LeBlanc P. Effects of lung resection on pulmonary function and exercise capacity. Thorax. 1990; 45 (7): 497-502.
207. Ali MK, Ewer MS, Atallah MR, et al. Regional and overall pulmonary function changes in lung cancer. Correlations with tumor stage, extent of pulmonary resection, and patient survival. J Thorac Cardiovasc Surg. 1983; 86 (1): 1-8.
208. Sarna L, Evangelista L, Tashkin D, et al. Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer. Chest. 2004; 125 (2): 439-445.
209. Rivera MP, Detterbeck FC, Socinski MA, et al. Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer. Chest. 2009; 135 (6): 1588-1595.
210. Leo F, Solli P, Spaggiari L, et al. Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications? Ann Thorac Surg. 2004; 77(1): 260-265.
211. Takeda S, Funakoshi Y, Kadota Y, et al. Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication? Ann Thorac Surg. 2006; 82 (1): 232-236.
212. Margaritora S, Cesario A, Cusumano G, et al. Is pulmonary function damaged by neoadjuvant lung cancer therapy? A comprehensive serial time-trend analysis of pulmonary function after induction radiochemotherapy plus surgery. J Thorac Cardiovasc Surg. 2010; 139 (6): 1457-1463.
213. Cerfolio RJ, Talati A, Bryant AS. Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications. Ann Thorac Surg. 2009; 88 (3): 930-935.
214. Fujita S, Katakami N, Takahashi Y, et al. Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancer. Eur J Cardiothorac Surg. 2006; 29 (6): 896-901.
215. Fishman A, Martinez F, Naunheim K, et al; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003; 348 (21): 2059-2073.
216. Duarte IG, Gal AA, Mansour KA, Lee RB, Miller JI. Pathologic findings in lung volume reduction surgery. Chest. 1998; 113 (3): 660-664.
217. Keller CA, Naunheim KS, Osterloh J, Espiritu J, McDonald JW, Ramos RR. Histopathologic diagnosis made in lung tissue resected from patients with severe emphysema undergoing lung volume reduction surgery. Chest. 1997; 111 (4): 941-947.
218. McKenna RJ Jr, Fischel RJ, Brenner M, Gelb AF. Combined operations for lung volume reduction surgery and lung cancer. Chest. 1996; 110 (4): 885-888.
219. Vaughan P, Oey I, Nakas A, Martin-Ucar A, Edwards J, Waller D. Is there a role for therapeutic lobectomy for emphysema? Eur J Cardiothorac Surg. 2007; 31(3): 486-490.
220. DeMeester SR, Patterson GA, Sundaresan RS, Cooper JD. Lobectomy combined with volume reduction for patients with lung cancer and advanced emphysema. J Thorac Cardiovasc Surg. 1998; 115 (3): 681-688.
221. Ojo TC, Martinez F, Paine R III, et al. Lung volume reduction surgery alters management of pulmonary nodules in patients with severe COPD. Chest. 1997; 112 (6): 1494-1500.
222. DeRose JJ Jr, Argenziano M, El-Amir N, et al. Lung reduction operation and resection of pulmonary nodules in patients with severe emphysema. Ann Thorac Surg. 1998; 65 (2): 314-318.
223. Rozenshtein A, White CS, Austin JHM, Romney BM, Protopapas Z, Krasna MJ. Incidental lung carcinoma detected at CT in patients selected for lung volume reduction surgery to treat severe pulmonary emphysema. Radiology. 1998; 207 (2): 487-490.
224. Allen GM. DeRose JJ Jr. Pulmonary nodule resection during lung volume reduction surgery. AORN. 1997; 66 (5): 808-810, 812,814.
225. Choong CK, Meyers BF, Battafarano RJ, et al. Lung cancer resection combined with lung volume reduction in patients with severe emphysema. J Thorac Cardiovasc Surg. 2004; 127 (5): 1323-1331.
226. Pompeo E, De Dominicis E, Ambrogi V, Mineo D, Elia S, Mineo TC. Quality of life after tailored combined surgery for stage I non-small-cell lung cancer and severe emphysema. Ann Thorac Surg. 2003; 76 (6): 1821-1827.
227. Nakajima T, Sekine Y, Yamada Y, et al. Long-term surgical outcome in patients with lung cancer and coexisting severe COPD. Thorac Cardiovasc Surg. 2009; 57 (6): 339-342.
228. Mentzer SJ, Swanson SJ. Treatment of patients with lung cancer and severe emphysema. Chest. 1999; 116 (suppl 6): 477S-479S.
229. Barrera R, Shi WJ, Amar D, et al. Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. Chest. 2005; 127 (6): 1977-1983.
230. Groth SS, Whitson BA, Kuskowski MA, Holmstrom AM, Rubins JB, Kelly RF. Impact of preoperative smoking status on postoperative complication rates and pulmonary function test results 1-year following pulmonary resection for non-small cell lung cancer. Lung Cancer. 2009; 64 (3): 352-357.
231. Nakagawa M, Tanaka H, Tsukuma H, Kishi Y. Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery. Chest. 2001; 120 (3): 705-710.
232. Mason DP, Subramanian S, Nowicki ER, et al. Impact of smoking cessation before resection of lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database study. Ann Thorac Surg. 2009; 88 (2): 362-370.
233. Nakamura H, Haruki T, Adachi Y, Fujioka S, Miwa K, Taniguchi Y. Smoking affects prognosis after lung cancer surgery. Surg Today. 2008; 38 (3): 227-231.
234. Slatore CG, Au DH, Hollingworth W. Cost-effectiveness of a smoking cessation program implemented at the time of surgery for lung cancer. J Thorac Oncol. 2009; 4 (4): 499-504.
235. Leone FT, Evers-Casey S, Toll BA, Vachani A. Treatment of tobacco use in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143 (5)(suppl):e61S-e77S.
236. Colt HG, Murgu SD, Korst RJ, Slatore CG, Unger M, Quadrelli S. Follow-up and surveillance of the lung cancer patient after curative-intent therapy: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143 (5)(suppl):e437S-e454S.
237. Ries AL, Make BJ, Lee SM, et al; National Emphysema Treatment Trial Research Group. The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest. 2005; 128 (6): 3799-3809.
238. Weinstein H, Bates AT, Spaltro BE, Thaler HT, Steingart RM. Influence of preoperative exercise capacity on length of stay after thoracic cancer surgery. Ann Thorac Surg. 2007; 84 (1): 197-202.
239. Bobbio A, Chetta A, Ampollini L, et al. Preoperative pulmonary rehabilitation in patients undergoing lung resection for non-small cell lung cancer. Eur J Cardiothorac Surg. 2008; 33 (1): 95-98.
240. Jones LW, Eves ND, Peterson BL, et al. Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical nonsmall cell lung cancer patients: a pilot study. Cancer. 2008; 113 (12): 3430-3439.
241. Cesario A, Ferri L, Galetta D, et al. Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer. Lung Cancer. 2007; 57 (2): 175-180.
242. Riesenberg H, Lübbe AS. In-patient rehabilitation of lung cancer patients-a prospective study. Support Care Cancer. 2010; 18 (7): 877-882.
243. Arbane G, Tropman D, Jackson D, Garrod R. Evaluation of an early exercise intervention after thoracotomy for non-small cell lung cancer (NSCLC), effects on quality of life, muscle strength and exercise tolerance: randomised controlled trial. Lung Cancer. 2011; 71 (2): 229-234.
244. Spruit MA, Janssen PP, Willemsen SCP, Hochstenbag MMH, Wouters EFM. Exercise capacity before and after an 8-week multidisciplinary inpatient rehabilitation program in lung cancer patients: a pilot study. Lung Cancer. 2006; 52 (2): 257-260.
245. Kaneda H, Saito Y, Okamoto M, Maniwa T, Minami K, Imamura H. Early postoperative mobilization with walking at 4 hours after lobectomy in lung cancer patients. Gen Thorac Cardiovasc Surg. 2007; 55 (12): 493-498.